Interested in 3-D printing applications in medicine, not just what we are doing today but what we could be doing in the future and how we get there? For example, can we print medical devices? Can we print permanent implants? Can we print drugs (i.e., new molecular entities)? Can we print living tissue? What are the technical and regulatory challenges these new technologies pose? Using case studies from a variety of clinical specialities, all of these and more will be discussed in this interactive webinar. Strategies for using regulation as a competitive advantage will also be discussed.
Understand what is currently being done in biomedical 3-D printing
Appreciate the technical and regulatory challenges and how to address them
Be aware of applications and technologies underdevelopment
Geared for both experienced medical professionals as well as those new to the industry, this webinar is designed for those who need a better understanding of the medical applications of 3-D printing from a clinical, regulatory and manufacturing perspective. Scientists, engineers and technicians working on device design and development, product and product development managers, business development managers, marketing managers, QA/QC personnel, regulatory affairs professionals, investment and acquisition specialists and field service engineers will all benefit from this webinar.
Michael Drues, Ph.D., is President of Vascular Sciences ( an education, training, & consulting company offering a broad range of services to medical device, pharmaceutical & biotechnology companies including stimulating & innovative educational programming, brainstorming sessions, prototype design, product development, benchtop & animal testing, regulatory strategy, intelligence & clinical trial design, FDA presentation preparation & defense, reimbursement, clinical acceptance, business development & technology assessment.
Dr. Drues received his BS, MS, and Ph.D. degrees in Biomedical Engineering from Iowa State University in Ames, Iowa. He has worked for and consulted with leading medical device, pharmaceutical and biotechnology companies ranging in size from start-ups to Fortune 100 companies. He also works on a regular basis for the U.S. Food and Drug Administration (FDA), Health Canada, the U.S. and European Patent Offices, the Centers for Medicare and Medicaid Services (CMS) and other regulatory and governmental agencies around the world.
Dr. Drues is an internationally recognized expert and featured keynote speaker on cutting-edge medical technologies and regulatory affairs. He conducts seminars and short courses for medical device, pharmaceutical and biotechnology companies, the U.S. Food and Drug Administration (FDA), Health Canada, the U.S. and European Patent Offices, the U.S. Centers for Medicare and Medicare Services (CMS) and other regulatory and governmental agencies around the world.
Finally, Dr. Drues is an Adjunct Professor of Medicine, Biomedical Engineering & Biotechnology at several universities and medical schools. He regularly teaches graduate courses in Regulatory Affairs and Clinical Trials, Clinical Trial Design, Medical Device Regulatory Affairs and Product Development, Combination Products, Pathophysiology, Medical Technology, Translational Medicine and Biotechnology.
View 2015 FAST CongressBrochure
Understanding Drug Toxicity: 3D Tissue Constructs, Organ Chips and the Hermeneutic Circle of Biology
Sci-Fi Come to Life: Improving Translational and Drug Research